Explore the Potential with AI-Driven Innovation
Our detailed focused library is generated on demand with advanced virtual screening and parameter assessment technology powered by the Receptor.AI drug discovery platform. This method surpasses traditional approaches, delivering compounds of better quality with enhanced activity, selectivity, and safety.
We pick out particular compounds from an extensive virtual database of more than 60 billion molecules. The preparation and shipment of these compounds are facilitated by our associate Reaxense.
In the library, a selection of top modulators is provided, each marked with 38 ADME-Tox and 32 parameters related to physicochemical properties and drug-likeness. Also, every compound comes with its best docking poses, affinity scores, and activity scores, providing a comprehensive overview.
We utilise our cutting-edge, exclusive workflow to develop focused libraries for enzymes.
Fig. 1. The sreening workflow of Receptor.AI
The procedure entails thorough molecular simulations of the catalytic and allosteric binding pockets, accompanied by ensemble virtual screening that factors in their conformational flexibility. When developing modulators, the structural modifications brought about by reaction intermediates are factored in to optimize activity and selectivity.
Our library is unique due to several crucial aspects:
partner
Reaxense
upacc
Q9BS40
UPID:
LXN_HUMAN
Alternative names:
Endogenous carboxypeptidase inhibitor; Protein MUM; Tissue carboxypeptidase inhibitor
Alternative UPACC:
Q9BS40; Q96PN2; Q9NQS6
Background:
Latexin, known as the endogenous carboxypeptidase inhibitor, plays a crucial role in regulating the activity of CPA1, CPA2, and CPA4 enzymes. Its alternative names include Protein MUM and Tissue carboxypeptidase inhibitor, highlighting its diverse functions across different tissues.
Therapeutic significance:
Understanding the role of Latexin could open doors to potential therapeutic strategies. Its potent inhibition of key enzymes suggests a significant role in controlling inflammation, making it a target of interest in developing treatments for inflammatory diseases.